Home Health Care Services (U.S.) — Industry Primer

NAICS 2022 code 621610. A plain-language guide to how the industry works, who owns it, how money is actually made, and the ways an investor can get exposure.

---

1. Overview

Home health care is medical care delivered where the patient lives instead of in a hospital or nursing facility: a nurse changing a wound dressing, a physical therapist rebuilding strength after a hip replacement, an aide helping a frail 85-year-old bathe and take medications, or a pump delivering intravenous antibiotics at the kitchen table. It sits at the crossroads of two powerful forces — an aging population and payers who want care moved to the cheapest safe setting, which is almost always the home.

The economics are unusual. This is a labor-intensive, reimbursement-driven service business, not a real-estate or capital-heavy one. An agency's product is a caregiver's hour or a nurse's visit; its profit is the spread between what a payer (mostly the government) reimburses and what it costs to recruit, retain, and deploy the worker. There is very little to own — no buildings, no beds, minimal equipment — so returns hinge on payer mix, wage inflation, and how efficiently caregivers are scheduled. Long-term demand growth is well supported, but returns depend far more on reimbursement, staffing, compliance, and acquisition execution than on demand alone.

Ways in for a public-market investor: a small and shrinking set of listed operators (personal-care, skilled home health, hospice, and home-infusion companies), plus large managed-care companies that now own the biggest home-health platforms. Ways in for a private investor: this is overwhelmingly a private, fragmented industry — buy or build an agency, back a private-equity roll-up, operate a franchise, partner with a hospital or health system, or invest in the financing and technology that supports agencies. Details are reserved for sections 4 and 10; the prose that follows treats the industry on its own terms, not as a stock sector.

---

2. What it is and how it is structured

The North American Industry Classification System (NAICS) defines 621610 as establishments primarily providing skilled, in-home health care — visiting-nurse services; home health aide services combined with skilled care; physical, occupational, and speech therapy at home; medical social work; home infusion and other high-acuity care; and in-home hospice. Think "medical care that comes to you." [5]

What it excludes (and why the boundary matters):

• Non-medical home care / homemaker and companion services — help with bathing, dressing, meals, and errands with no skilled-nursing component — is classified separately under NAICS 624120, Services for the Elderly and Persons with Disabilities. [5]
• Renting home-health equipment (wheelchairs, oxygen, hospital beds) is NAICS 532283; retail sale of such equipment is NAICS 456199. [5]
• Nursing facilities and residential care are generally NAICS 623; independent physician and therapist practices fall under other 621 codes. Inpatient and residential care sit outside 621610; in-home hospice sits inside it. [5]

This matters because the "care at home" a general investor pictures — the fast-growing world of personal-care aides for seniors aging in place — straddles 621610 and 624120, and many of the industry's largest operators run both skilled and non-medical lines. So the federal 621610 figures in the next section understate the total "care at home" economy.

Ownership mix. Delivery is almost entirely private-sector and mixed in form: local independent agencies, for-profit operators (the majority), non-profits (visiting-nurse associations, and BAYADA, which converted to non-profit status in 2019), hospital and health-system joint ventures, payer-owned platforms, family businesses, public companies, and private-equity-backed operators. [24][27] Federal statistics do not provide a reliable national split by ownership type. But the money is overwhelmingly public: Medicare and Medicaid together fund roughly half or more of industry revenue, which makes this a private industry running on a government meter. [7][12]

The operating model is local even when ownership is national. Referral relationships, clinician availability, branch density, state licensing, payer contracts, and reputation determine who wins a given market.

---

3. How big it is

Federal business statistics for NAICS 621610 (our ground-truth figures). Receipts, firm count, and concentration are from the 2022 Economic Census; employment, establishments, and payroll are from 2023 County Business Patterns (CBP) — so this is a blend of two survey years, not a single-year snapshot.

(CBP = County Business Patterns, the Census Bureau's annual count of employer establishments. SBA = Small Business Administration.)

Two facts jump out. First, it is enormous in labor terms: over 1.6 million paid workers — one of the largest employment bases of any single U.S. industry — and payroll ($61.7B) eats more than half of receipts, the clearest possible signal that this is a people business. Second, it is extraordinarily fragmented. A firm can run several establishments (so the two counts are not interchangeable), but average revenue per firm is only about $4 million, and the concentration data confirm an almost atomistic market:

The HHI is a standard concentration score on a 0–10,000 scale; U.S. antitrust regulators treat anything below 1,500 as "unconcentrated." At 42.2, the national market has effectively no concentration — the fifty largest companies combined don't reach even 34% of revenue, and no single firm has meaningful national market power. [3]

The undercount caveat. Two adjacent pools of activity are missing from these figures. (1) CBP and the Economic Census primarily measure employer establishments with paid employees; they exclude nonemployer and self-employed activity and generally exclude government-owned establishments — which understates industries full of tiny operators. Our ground-truth file does not include a national nonemployer total, so none is estimated here. [2][6] (2) The entire non-medical personal-care/homemaker segment sits in NAICS 624120, and a growing army of self-directed Medicaid caregivers — often a family member hired directly by the beneficiary and paid as an individual provider — never shows up as a business establishment at all. Add those in and the true "care at home" economy is materially larger than $114 billion. Third-party market researchers, using a broader "home healthcare" definition, put the U.S. market around $107 billion and up for 2025, growing roughly 7–12% a year — consistent with, but broader than, the federal receipts figure. [7] Our federal file also does not provide national profit margins, payer mix, or industry-wide cash flow, so figures for those below come from named third-party sources, not the Census.

---

4. The investable universe

Public companies. The listed field has shrunk sharply through consolidation (see section 8) — a defining fact for stock investors. Public filings routinely combine home health with hospice, personal care, pharmacy, senior living, or insurance, so treat the table below as an exposure map, not a pure-play classification. Revenue is most recent full year; market caps are point-in-time and move daily.

Companies that recently left the public market — the key signal:

• Amedisys (formerly AMED) — became a wholly owned subsidiary of UnitedHealth's Optum on August 14, 2025; delisted. [21][22]
• LHC Group — acquired by Optum in 2023. [24]
• Enhabit (formerly EHAB) — taken private by private-equity firm Kinderhook Industries (~$1.1 billion); deal completed May 15, 2026. [23]
• Kindred at Home — bought by Humana, now operated as CenterWell. [24]

Major private and other owners (where most of the industry actually lives):

• Optum (UnitedHealth) and CenterWell (Humana) — the two managed-care giants are now among the largest home-health-and-hospice providers in the country. [21][24]
• Help at Home (Centerbridge & Vistria) — a leading Medicaid personal-care platform, 20+ acquisitions since 2020. [24]
• Compassus — backed by private-equity firm TowerBrook Capital Partners and non-profit health system Ascension. [25]
• Elara Caring — announced a strategic investment from Ares' private-equity group and DaVita, expected to close later in 2026. [26]
• BAYADA Home Health Care — non-profit, 360+ offices. [27]
• PE roll-up platforms and franchises: Gentiva (Clayton, Dubilier & Rice), Senior Helpers/Altocare (Waud), Comfort Keepers, Synergy HomeCare, Home Instead (Honor), Interim HealthCare, HomeWell — plus local hospital-affiliated and family-owned agencies across the long tail. [24]

Bottom line: public investors have a handful of choices and fewer every year; private investors have the whole fragmented field.

---

5. How the money works

Owners make money on a simple but unforgiving equation: reimbursement rate minus the fully-loaded cost of the caregiver hour or visit, times volume, minus overhead. Payer mix is usually more decisive than headline patient demand.

Payer mix is destiny. Each dollar of revenue is priced differently by who pays:

• Original (fee-for-service) Medicare. Covered patients must generally be homebound and need part-time or intermittent skilled care. The agency (a Medicare-certified home health agency, or HHA) is paid a national, standardized amount for a 30-day period under the Patient-Driven Groupings Model (PDGM) — set by the patient's diagnosis, functional status, referral source, and local wages rather than the number of visits. Home health services generally carry no patient copayment. [7][11] These are the industry's fattest margins: the independent advisory body MedPAC (Medicare Payment Advisory Commission) reported a 2023 Medicare fee-for-service margin for freestanding agencies of 20.2%, projecting about 19% for 2025 — very high for health care. [8]
• Medicare Advantage (MA) — the private managed-care version of Medicare, now covering more than half of Medicare enrollees — contracts through networks and usually pays per-visit, lower rates with added authorization and utilization controls. As MA takes share from traditional Medicare, it squeezes agency economics. [8]
• Medicaid pays mostly for hourly personal care and other home- and community-based services (HCBS); eligibility, rates, waiting lists, and rules vary by state, and margins are thin. [12]
• Commercial insurance and private pay are a smaller, higher-price slice — dominant in non-medical companion care that Medicare does not cover.

Labor is ~60%+ of the cost base and the binding constraint. The main cost items are clinical wages and benefits, travel and mileage, recruiting, supplies, scheduling, clinical supervision, billing and collections, and compliance. Because caregivers dominate the cost structure, the metrics that matter are operational, not financial-engineering:

• Caregiver utilization / billable hours — every unbilled hour of a scheduled worker is pure loss.
• Turnover and fill rate — turnover runs 75–80%; each departure means recruiting, training, and lost capacity. [17]
• Revenue per episode / per visit / per hour versus the wage paid.
• Case-mix and LUPA avoidance — under Medicare, an ultra-short episode triggers a LUPA (Low-Utilization Payment Adjustment) that pays per-visit instead of the full 30-day bundle, crushing episode economics.
• Census, admissions, average length of stay, visits per episode, denial/recoupment rates, and accounts-receivable days — the volume-and-collection drivers.

It is asset-light and scales by density. There are no hospital wings to build; growth comes from adding referral relationships and packing caregiver routes tightly in a geography. The winning strategy is local density plus back-office scale — bigger players get payer-contracting leverage and spread fixed compliance/IT costs across more visits. The flip side, low barriers to entry, is exactly why 27,774 firms coexist and national concentration is so low. [1]

---

6. What drives demand

• Demographics. The U.S. Census Bureau projects that adults 65 and older will outnumber children under 18 in 2029, and by 2030 the entire baby-boom generation is over 65; the 80+ cohort (the heaviest users) grows fastest thereafter. [19]
• Aging in place. A 2024 AARP survey found 75% of adults 50 and older want to stay in their current home as they age, and 73% want to remain in their community. [20]
• Payer economics. Home care is the cheapest safe setting, so Medicare, Medicaid, and MA plans actively steer patients out of hospitals and nursing homes; the spread of hospital-at-home programs pushes even acute care into the home. [7]
• Hospital and skilled-nursing substitution. Shorter inpatient stays discharge patients "quicker and sicker," and demand is rising for pediatric, complex, and infusion care — all feeding home-health referrals.
• Workforce supply as a demand ceiling. Uniquely for this industry, demand is not the problem — staffing is. The Bureau of Labor Statistics (BLS) projects employment in the broader home-health-services category (NAICS 621600) to grow 20.0% from 2023 to 2033 — directional, since 621600 is broader than 621610 — and direct-care work is among the fastest-growing occupations, with roughly 6.1 million direct-care job openings projected by 2034. [16][17] Yet turnover and low pay make those slots hard to fill, so growth is often capacity-constrained, not demand-constrained: agencies routinely have referrals they cannot staff.

---

7. Regulation

Home health is one of the most heavily regulated corners of health care, and regulation is the business model because the government is the customer.

• Medicare certification & Conditions of Participation, plus state licensure. Medicare-certified HHAs must meet federal Conditions of Participation under 42 Code of Federal Regulations (CFR) Part 484 — patient acceptance, plans of care, clinical supervision, assessments, documentation, quality reporting, and patient rights — the price of admission to bill Medicare/Medicaid. [13] Many states add licensing, staffing, and certificate-of-need (CON) rules that can limit new-agency entry. [18]
• Medicare payment rules (the single biggest annual event). CMS (the Centers for Medicare & Medicaid Services) updates the Home Health Prospective Payment System every year. The CY2026 final rule (CMS-1828-F) set an aggregate –1.3% Medicare payment change (about $220 million) — far milder than the –6.4% CMS first proposed. It layers a permanent behavioral-adjustment cut of –1.023% on top of a –3.0% temporary "clawback," with 2026 the first year agencies feel the temporary recoupment of what CMS says were overpayments under PDGM. [9][10] Pointing to ~20% margins, MedPAC recommended a steeper 7% reduction for 2026 — an estimate, not a result already realized. [8]
• OASIS and value-based purchasing. The Outcome and Assessment Information Set (OASIS) patient assessment feeds payment and quality reporting, and Home Health Value-Based Purchasing (HHVBP) — nationwide since 2023 — ties a share of Medicare payment to quality scores. [14] The Review Choice Demonstration adds pre-claim review in high-fraud states.
• Medicaid "80/20 rule." The 2024 HCBS Access Rule requires agencies to spend at least 80% of Medicaid payments for homemaker, home-health-aide, and personal-care services on direct-care-worker compensation, phased in through 2030 (self-directed models where the beneficiary sets the wage are exempt). This directly compresses agency margins on Medicaid personal care. [15]
• Electronic Visit Verification (EVV) — federally mandated GPS/time capture of Medicaid personal-care visits — and the Medicare rule that the patient be homebound under a plan of care with a face-to-face physician encounter. [11]
• Compliance risk is unusually material. The HHS Office of Inspector General (OIG) reported a 7.7% improper-payment error rate on 2023 home-health claims — roughly $1.2 billion. [28] Enforcement is active: in 2026 the Department of Justice (DOJ) announced that Traditions Health agreed to pay $34 million to resolve allegations of medically unnecessary claims and improper referral payments (allegations not judicially determined). [29] Audits, pre-claim review, and payment moratoria can hit an agency's cash flow abruptly.

---

8. Competitive dynamics and consolidation

The paradox: a nationally atomistic industry (HHI 42.2) that is nonetheless consolidating fast at the top. [3] Two dynamics run in parallel.

The long tail stays fragmented. Low capital requirements and local, relationship-driven referral networks mean tens of thousands of small agencies persist; no one can corner a national market. Competition is fiercest locally, where hospitals, physicians, MA plans, and skilled-nursing facilities control referrals and every agency competes for the same scarce nurses, therapists, aides, and branch managers.

The top is rolling up — and going private. Two threads:

1. Payviders. Managed-care giants are buying the delivery side. Optum (UnitedHealth) now owns both LHC Group (2023) and Amedisys (closed 2025), making it a home-health leader; Humana's CenterWell (built on the former Kindred at Home) is the other giant. Owning the provider lets an insurer capture care in its cheapest setting and keep the margin in-house. [21][24]
2. Private equity. Nearly every large platform outside the payviders is PE-backed — Bain (Aveanna's original sponsor), CD&R (Gentiva), Centerbridge/Vistria (Help at Home), Waud (Senior Helpers/Altocare), TowerBrook with Ascension (Compassus), Ares with DaVita (Elara Caring), and franchise consolidators — all rolling up smaller agencies for scale. [24][25][26]

Scale can improve recruiting, scheduling, payer contracting, compliance, technology, and acquisition integration — but that is an investment judgment, not a guarantee; big platforms can also carry bureaucracy, leverage, and uneven local execution. The UnitedHealth–Amedisys deal shows the tension: the DOJ forced divestiture of roughly 164 locations on antitrust grounds, with buyers including BrightSpring and Pennant (Pennant paid ~$146.5M for 54 assets). [21] Consolidation is happening, but regulators watch local-market concentration even while the national picture stays unconcentrated. The likely result is continued roll-up at the top alongside a durable long tail of local providers.

---

9. Risks

• Reimbursement risk (the dominant risk). Medicare rate cuts (the 2026 temporary clawback begins; MedPAC pushes for more), plus the shift of volume from high-margin traditional Medicare to lower-paying Medicare Advantage, squeeze the profit engine. [8][9]
• Medicaid funding cuts. The 2025 reconciliation law (H.R. 1, the "One Big Beautiful Bill Act," signed July 4, 2025) is estimated to cut federal Medicaid spending by about $911 billion (~14%) over a decade. Because home- and community-based services are optional Medicaid benefits, they are exposed to being trimmed first — longer waiting lists, tighter eligibility, and rate pressure. Over 5 million people receive Medicaid home care today. [16]
• Labor shortage and wage inflation. Median direct-care worker pay was about $16.77/hour in 2024, with median annual earnings near $26,000; turnover of 75–80% caps growth and drives up recruiting cost, and the 80/20 rule further limits how much Medicaid revenue can flow to overhead and profit. [15][17]
• Immigration policy. The direct-care workforce is heavily immigrant; tighter immigration reduces an already-scarce labor supply.
• Compliance and fraud enforcement. Unsupported documentation, improper coding, invalid face-to-face encounters, kickbacks, audits, and repayment demands are a live and material threat (OIG error rate 7.7%; Traditions Health's $34M settlement). [28][29]
• Payer and referral concentration. Dependence on Medicare, a few MA plans, state Medicaid, or a handful of referral sources leaves an agency exposed to any one of them changing terms.
• Leverage. Many PE-owned platforms carry heavy debt, exposing them to interest-rate and refinancing risk when reimbursement or branch margins weaken.
• Measurement risk (for public-market investors). Reported results often combine home health with hospice, pharmacy, personal care, senior living, or insurance — obscuring the economics of NAICS 621610 itself. Patient-safety events, privacy failures, cyberattacks, or poor quality scores can also damage referrals and payer relationships.

---

10. How to invest and the outlook

Public-market routes. Direct operator exposure is available through the remaining listed names — Addus (ADUS) and Aveanna (AVAH) for personal care and home health, Pennant (PNTG) for home health/hospice, Option Care Health (OPCH) for home infusion, BrightSpring (BTSG) for a diversified home-and-community platform, National HealthCare (NHC) for a diversified operator, and Chemed (CHE) for hospice-adjacent exposure. A more diluted route is the payviders — UnitedHealth (UNH) and Humana (HUM) — where home health is a small slice of a much larger insurer. Before buying any of these, the first question is how much reported revenue actually comes from skilled home health versus hospice, pharmacy, personal care, senior living, or insurance. Then review:

• Medicare, MA, Medicaid, commercial, and private-pay mix.
• Same-branch admissions, census, revenue per episode, and visit productivity.
• Clinician retention, contract-labor use, and wage trends.
• Quality scores, hospitalization rates, audits, denials, and reserves.
• Branch-level margins, accounts-receivable days, debt, and free cash flow.
• Organic vs. acquisition growth — and normalize enterprise-value-to-EBITDA (earnings before interest, taxes, depreciation, and amortization) and free-cash-flow yield for both acquisitions and reimbursement changes before comparing multiples.

The important caveat: the listed universe is thin and shrinking — Amedisys, LHC, Kindred, and Enhabit have all been absorbed — so public investors should expect continued take-privates and acquisitions (which can be premium-priced exits for existing shareholders).

Private routes. This is where most of the opportunity sits: single-agency acquisitions, regional roll-ups, health-system joint ventures, backing or co-investing in a PE platform, buying a franchise (Comfort Keepers, Senior Helpers, Interim, Synergy, HomeWell, Home Instead), or investing in the structured credit and revenue-cycle/scheduling software that agencies depend on. The SBA classifies agencies with up to $19 million in annual receipts as small businesses — a reminder that most of the 27,774 firms are acquirable, owner-operated units. [4] Value is created by local density, caregiver retention, favorable payer mix (more private-pay and Medicare, less thin-margin Medicaid), and eventual sale into a consolidating market. Diligence should verify licenses, CON status, payer contracts, referral sources, clinician employment, billing and audit history, ownership disclosures, working capital, and branch-level profitability.

Near-term outlook (forward-looking). The demand backdrop is as strong as any industry in the economy — an aging population, overwhelming preference to age in place, and payers pushing care home. The constraints are on the supply and payment sides. Expect the 2026 Medicare clawback to pressure skilled-home-health margins, Medicaid cuts under H.R. 1 to phase in as a multi-year overhang on the personal-care segment, and labor to remain the true ceiling on growth. The likely result is continued consolidation — payviders and PE buying scale, weaker independents selling — with the winners being operators who combine local referral density, reliable clinician capacity, strong quality performance, diversified payer exposure, and disciplined acquisition practices. The paradox to underwrite: a secularly growing end-market whose profits are perpetually rationed by government payers and a scarce workforce.

---

Sources

1. U.S. Census Bureau, "All Sectors: Summary Statistics for the U.S., States, and Selected Geographies: 2022" (Economic Census; NAICS 621610 — receipts, firms). https://data.census.gov/table/ECNBASIC2022.EC2200BASIC?codeset=naics~621610&g=010XX00US
2. U.S. Census Bureau, "County Business Patterns 2023" (NAICS 621610 — employment, establishments, payroll). https://data.census.gov/table/CBP2023.CB2300CBP
3. U.S. Census Bureau, "Selected Sectors: Concentration of Largest Firms for the U.S.: 2022" (NAICS 621610 — CR4/8/20/50, HHI). https://data.census.gov/table/ECNSIZE2022.EC2200SIZECONCEN?codeset=naics~621610&g=010XX00US
4. U.S. Small Business Administration, "Table of Small Business Size Standards," 2023. https://www.sba.gov/document/support-table-size-standards
5. U.S. Census Bureau, "2022 NAICS — 621610 Home Health Care Services (definition and exclusions)" and 2022 NAICS Manual. https://www.census.gov/naics/?input=621610&year=2022
6. U.S. Census Bureau, "Economic Census: NAICS Codes & Understanding Industry Classification" (employer-only coverage / nonemployer exclusion). https://www.census.gov/programs-surveys/economic-census/year/2022/guidance/understanding-naics.html
7. Fortune Business Insights, "U.S. Home Healthcare Services Market Size, Share & Growth," 2025. https://www.fortunebusinessinsights.com/u-s-home-healthcare-services-market-105568
8. Medicare Payment Advisory Commission (MedPAC), "Report to the Congress: Medicare Payment Policy — Home Health Care Services (Ch. 7)," March 2025. https://www.medpac.gov/wp-content/uploads/2025/03/Mar25_Ch7_MedPAC_Report_To_Congress_SEC.pdf
9. Centers for Medicare & Medicaid Services (CMS), "CY2026 Home Health Prospective Payment System Final Rule (CMS-1828-F) Fact Sheet," 2025. https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2026-home-health-prospective-payment-system-final-rule-cms-1828-f
10. Home Health Care News, "CMS Finalizes 2026 Home Health Medicare Payment Rule With 1.3% Aggregate Reduction," 2025. https://homehealthcarenews.com/2025/11/cms-finalizes-2026-home-health-medicare-payment-rule-with-1-3-aggregate-reduction/
11. Medicare.gov, "Home Health Services Coverage" (homebound requirement; no copayment). https://www.medicare.gov/coverage/home-health-services
12. Medicaid.gov, "Home & Community Based Services." https://www.medicaid.gov/medicaid/home-community-based-services
13. Centers for Medicare & Medicaid Services, "Home Health Agencies: Conditions of Participation (42 CFR Part 484)," 2024. https://www.cms.gov/medicare/health-safety-standards/conditions-coverage-participation/home-health
14. Centers for Medicare & Medicaid Services, "Home Health Quality Reporting Requirements" (OASIS; HHVBP). https://www.cms.gov/medicare/quality/home-health/home-health-quality-reporting-requirements
15. Polsinelli, "The 80/20 Rule is Here: CMS Finalizes HCBS Care Worker Payment Requirements," 2024. https://www.polsinelli.com/publications/the-80-20-rule-is-here-cms-finalizes-hcbs-care-worker-payment-requirements
16. KFF, "Medicaid Home Care (HCBS) in 2025" (H.R. 1 / Medicaid cuts; >5M recipients). https://www.kff.org/medicaid/medicaid-home-care-hcbs-in-2025/
17. PHI, "Direct Care Workers in the United States: Key Facts 2025" (turnover, median pay, projected openings). https://www.phinational.org/resource/direct-care-workers-in-the-united-states-key-facts-2025/
18. U.S. Bureau of Labor Statistics, "Industry and Occupational Employment Projections Overview and Highlights, 2023–33," 2024. https://www.bls.gov/opub/mlr/2024/article/industry-and-occupational-employment-projections-overview-and-highlights-2023-33.htm
19. U.S. Census Bureau, "U.S. Population Projected to Begin Declining in Second Half of Century," 2023 (65+ outnumber children in 2029). https://www.census.gov/newsroom/press-releases/2023/population-projections.html
20. AARP, "New AARP Report: Majority of Adults 50-plus Want to Age in Place," 2024. https://www.aarp.org/press/releases/2024-12-10-new-aarp-report-majority-adults-50-plus-age-place-policies-and-communities-must-catch-up.html
21. U.S. Department of Justice, "Justice Department Requires Broad Divestitures to Resolve Challenge to UnitedHealth's Acquisition of Amedisys," 2025 (~164 locations; BrightSpring/Pennant buyers). https://www.justice.gov/opa/pr/justice-department-requires-broad-divestitures-resolve-challenge-unitedhealths-acquisition
22. Amedisys, "Form 8-K: Completion of Acquisition by UnitedHealth Group," Aug. 14, 2025. https://www.sec.gov/Archives/edgar/data/896262/000110465925078145/tm2523306d1_8k.htm
23. Enhabit, "Form 8-K: Completion of Acquisition by Kinderhook Industries," May 15, 2026. https://www.sec.gov/Archives/edgar/data/1803737/000119312526225491/d123700d8k.htm
24. Home Health Care News, "Where the Largest Home-Based Care Providers Are Scoring Key Wins" (private equity / payvider ownership; LHC, Kindred/CenterWell, Help at Home, franchises), 2025. https://homehealthcarenews.com/2025/11/where-the-largest-home-based-care-providers-are-scoring-key-wins/
25. TowerBrook Capital Partners, "Responsible Ownership Report: Compassus" (with Ascension), 2024. https://www.towerbrook.com/TowerBrook_Responsible_Ownership-2024-printing.pdf
26. DaVita, "Elara Caring Secures New Strategic Investment from Ares and DaVita," 2026. https://newsroom.davita.com/2026-02-02-elara-caring-secures-new-strategic-investment-from-ares-and-davita/
27. BAYADA Home Health Care, "BAYADA's Non-profit Transition Offers Stability to Clients and Employees," 2019. https://blog.bayada.com/bayada-news-blog/bayadas-nonprofit-transition-offers-stability-to-clients-and-employees
28. HHS Office of Inspector General, Medicare home health improper-payment / provider compliance reporting, 2024 (7.7% error rate; ~$1.2B). https://oig.hhs.gov/reports/all/2024/medicare-home-health-agency-provider-compliance-audit-bridge-home-health/
29. U.S. Department of Justice, "Traditions Health Agrees to Pay $34M to Resolve False Claims Act Liability Relating to Home Health Services," 2026. https://www.justice.gov/opa/pr/traditions-health-agrees-pay-34m-resolve-false-claims-act-liability-relating-home-health
30. SEC Form 10-K filings, fiscal 2025: Addus HomeCare (ADUS), Aveanna Healthcare (AVAH), BrightSpring Health Services (BTSG), The Pennant Group (PNTG), National HealthCare (NHC), Humana (HUM), UnitedHealth Group (UNH). https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany
31. Mertz Taggart, "Home-Based Care Public Company Roundup, Q3/Q4 2025." https://www.mertztaggart.com/post/home-based-care-public-company-roundup-q3-2025
32. Businesswire, "Addus HomeCare Announces Fourth Quarter and Year End 2025 Financial Results," 2026. https://www.businesswire.com/news/home/20260223140576/en/
33. Seeking Alpha, "Option Care Health raises 2025 revenue midpoint to $5.625B," 2025. https://seekingalpha.com/news/4511927-option-care-health-raises-2025-revenue-midpoint-to-5_625b
34. EveryTicker, "Home Health & Hospice Stocks — Market Data" (market capitalizations), 2026. https://everyticker.com/category/home-health-hospice